Alseres Pharmaceuticals Inc ALSE:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 10/18/23 EDT
0.005UNCH (UNCH)
52 week range
0.00 - 0.01
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.005
  • 52 Week High0.01
  • 52 Week High Date10/18/23
  • 52 Week Low0.00
  • 52 Week Low Date10/18/23

Key Stats

  • Market Cap153,178.588
  • Shares Out30.64M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-1.27
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.005
  • 52 Week High0.01
  • 52 Week High Date10/18/23
  • 52 Week Low0.00
  • 52 Week Low Date10/18/23
  • Market Cap153,178.588
  • Shares Out30.64M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-1.27
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-843,800.008
  • ROE (TTM)-
  • Revenue (TTM)473,720.014
  • Gross Margin (TTM)-
  • Net Margin (TTM)-163.94%
  • Debt To Equity (MRQ)-76.66%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alseres Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Alseres Pharmaceuticals, Inc. is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). The Company's lead product candidate is Altropane. The Company's Altropane product is a molecular imaging agent used to diagnose Parkinson's disease and dementia. The Company is focused on entering into partnerships to ensure development and commercialization of its product.
Peter Savas
Chairman of the Board, Chief Executive Officer
Kenneth Rice Jr., J.D.
Chief Financial Officer, Executive Vice President - Finance and Administration, Secretary
Address
275 Grove Street, Suite 2-400
Auburndale, MA
02466
United States

Top Peers

SYMBOLLASTCHG%CHG
TLOG
TetraLogic Pharmaceuticals Corp
0.00UNCHUNCH
AMBS
Amarantus Bioscience Holdings Inc
0.0001UNCHUNCH
CALA
Calithera Biosciences Inc
0.02UNCHUNCH
CFRXQ
ContraFect Corp
0.02UNCHUNCH
ALLR
Allarity Therapeutics Inc
0.5758-0.0239-3.9853%